GMP IPO
📋 Filings Intelligence
About Contact
LIVE - Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement - financial results, order wins, dividends, mergers and more. Updated live.

-
Filed today
-
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings -

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Kilitch Drugs India Ltd

Kilitch Drugs India Ltd Board Meeting Nov 6 to Approve Q2 FY27 Results

BOARD ◆ Monitor Closely LOW RISK
📅 Filed on BSE: 02 Nov 2026, 04:20 PM IST  ·  BSE ID: f1b40719-f2d2-4b3a-bd62-31b806b47817
View Original BSE Filing (PDF)
💡
In Simple Terms
Kilitch Drugs India is meeting on November 6, 2026, to approve its latest financial results for the period ending September 30, 2026.
🤖 AI Summary
  • Board meeting scheduled November 6, 2026, to approve Q2 FY27 results.
  • Unaudited standalone and consolidated financial results for review.
  • Period covered: Quarter and half year ended September 30, 2026.
  • Trading window closure effective October 1, 2026.
🏢 How This Affects the Company
💰
Financial Impact
The upcoming board meeting will lead to the disclosure of the company's financial performance for the second quarter and half-year ending September 30, 2026, impacting investor understanding of its earnings.
👥 What This Means For Shareholders
✅
Action Required
No action is required from shareholders at this time. Shareholders should await the financial results announcement.
👤
Who Is Affected
All shareholders will be affected by the upcoming financial results disclosure, which will provide insights into the company's performance for the period.
🔍
Management Signal
Management is adhering to regulatory timelines for financial reporting and insider trading compliance.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List - track these upcoming events
Board meeting on November 6, 2026, for results approval.
Disclosure of unaudited Q2 FY27 financial results.
Reopening of the trading window 48 hours post-disclosure.
LOW RISK Routine regulatory disclosure of upcoming board meeting for financial results.
💡 Investor Takeaway
Kilitch Drugs India will announce its unaudited standalone and consolidated financial results for the quarter and half-year ended September 30, 2026, on November 6, 2026. The trading window is closed from October 1, 2026.
❓ Frequently Asked Questions
When is the Kilitch Drugs India board meeting scheduled?
The Kilitch Drugs India board meeting is scheduled for Friday, November 6, 2026.
What will be considered at the Kilitch Drugs India board meeting?
The meeting will consider and approve the unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2026.
When is the trading window closed for Kilitch Drugs India?
The trading window for Kilitch Drugs India has been closed from October 1, 2026, and will reopen 48 hours after the financial results are disclosed.

Questions based on this BSE filing only. For information purposes.

You've read one filing

There are 32,000 more, and one of them is about a company you own

Follow a company and we'll email you the moment it files again - explained, not just forwarded. Free.

  • Follow companies and get filings by email
  • Save any filing to read later
  • Two full AI analyses every month, free

No card needed. Sign in with Google in two taps.

⚠️ For Information Only - Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector - takes 5 seconds.